Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies
Koen C. van Son, L.C. te Nijenhuis-Noort, Sebastiaan C. Boone, Dennis O. Mook‐Kanamori, Adriaan G. Holleboom, Paul R. Roos, Hildo J. Lamb, Gabrielle Alblas, Minneke J. Coenraad, Frits R. Rosendaal, Renée de Mutsert, Maarten E. Tushuizen (2024). Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in a middle-aged population with overweight and normal liver enzymes, and diagnostic accuracy of noninvasive proxies. Medicine, 103(1), pp. e34934-e34934, DOI: 10.1097/md.0000000000034934.
Article273 days agoIn vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1
Adriaan G. Holleboom, Lily Jakulj, Remco Franssen, J Decaris, Menno Vergeer, Joris Koetsveld, Jayraz Luchoomun, Alexander Glass, Marc Hellerstein, John J.P. Kastelein, G. Kees Hovingh, Jan Albert Kuivenhoven, Albert K. Groen, Scott Turner, Erik S.G. Stroes (2013). In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1. , 54(7), DOI: https://doi.org/10.1194/jlr.p028449.
Article18 days agoIn vivo Tissue Cholesterol Efflux is Impaired in Carriers of Mutations in APOA1 and ABCA1
Adriaan G. Holleboom, Remco Franssen, Lily Jakulj, J Decaris, Menno Vergeer, Joris Koetsveld, Marc Hellerstein, John J.P. Kastelein, Albert K. Groen, Scott Turner, Erik S.G. Stroes (2010). In vivo Tissue Cholesterol Efflux is Impaired in Carriers of Mutations in APOA1 and ABCA1. , 122(21)
Article18 days ago